Cargando…

Structures of Ebola Virus GP and sGP in Complex with Therapeutic Antibodies

The Ebola virus (EBOV) GP gene encodes two glycoproteins. The major product is a soluble, dimeric glycoprotein termed sGP that is secreted abundantly. Despite the abundance of sGP during infection, little is known regarding its structure or functional role. A minor product, resulting from transcript...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pallesen, Jesper, Murin, Charles D., de Val, Natalia, Cottrell, Christopher A., Hastie, Kathryn M., Turner, Hannah L., Fusco, Marnie L., Flyak, Andrew I., Zeitlin, Larry, Crowe, James E., Andersen, Kristian G., Saphire, Erica Ollmann, Ward, Andrew B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003320/ https://www.ncbi.nlm.nih.gov/pubmed/27562261 http://dx.doi.org/10.1038/nmicrobiol.2016.128

Ejemplares similares

Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies
por: Bornholdt, Zachary A., et al.
Publicado: (2016)

Ebola sGP—The first viral glycoprotein shown to be C-mannosylated
por: Falzarano, Darryl, et al.
Publicado: (2007)

Antibodies to the Glycoprotein GP2 Subunit Cross-React between Old and New World Arenaviruses
por: Amanat, Fatima, et al.
Publicado: (2018)

BROADLY NEUTRALIZING ANTIBODIES FROM HUMAN SURVIVORS TARGET A CONSERVED SITE IN THE EBOLA VIRUS GLYCOPROTEIN HR2/MPER REGION
por: Flyak, Andrew I., et al.
Publicado: (2018)

Ebola Virus Glycoprotein Needs an Additional Trigger, beyond Proteolytic Priming for Membrane Fusion
por: Bale, Shridhar, et al.
Publicado: (2011)

gp41: HIV's shy protein
por: Zwick, Michael B, et al.
Publicado: (2004)

Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding Site
por: Howell, Katie A., et al.
Publicado: (2016)

The role of the charged residues of the GP2 helical regions in Ebola entry
por: Jiang, Haiqing, et al.
Publicado: (2009)

Designs and Characterization of Subunit Ebola GP Vaccine Candidates: Implications for Immunogenicity
por: Agnolon, Valentina, et al.
Publicado: (2020)

Antibody Repertoires to the Same Ebola Vaccine Antigen Are Differentially Affected by Vaccine Vectors
por: Meyer, Michelle, et al.
Publicado: (2018)

Glycan shield of the ebolavirus envelope glycoprotein GP
por: Peng, Weiwei, et al.
Publicado: (2022)

Comprehensive Functional Analysis of N-Linked Glycans on Ebola Virus GP1
por: Lennemann, Nicholas J., et al.
Publicado: (2014)

Shed GP of Ebola Virus Triggers Immune Activation and Increased Vascular Permeability
por: Escudero-Pérez, Beatriz, et al.
Publicado: (2014)

Ebola GP-Specific Monoclonal Antibodies Protect Mice and Guinea Pigs from Lethal Ebola Virus Infection
por: Qiu, Xiangguo, et al.
Publicado: (2012)

Expression of the Heterotrimeric GP2/GP3/GP4 Spike of an Arterivirus in Mammalian Cells
por: Matczuk, Anna Karolina, et al.
Publicado: (2022)

Lassa virus glycoprotein: stopping a moving target
por: Hastie, Kathryn M, et al.
Publicado: (2018)

Identification of Ebola Virus Inhibitors Targeting GP2 Using Principles of Molecular Mimicry
por: Singleton, Courtney D., et al.
Publicado: (2019)

Ebola Virus GP Activates Endothelial Cells via Host Cytoskeletal Signaling Factors
por: Moni, Benedicte Mpia, et al.
Publicado: (2022)

The Ebola Virus VP30-NP Interaction Is a Regulator of Viral RNA Synthesis
por: Kirchdoerfer, Robert N., et al.
Publicado: (2016)

Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector
por: Khattar, Sunil K., et al.
Publicado: (2013)

Decreased levels of the serum inflammatory biomarkers, sGP130, IL-6, sCRP and BAFF, are associated with increased likelihood of AIDS related Kaposi’s sarcoma in men who have sex with men
por: Bolanos, Rachel, et al.
Publicado: (2018)

Ebola-GP DNA Prime rAd5-GP Boost: Influence of Prime Frequency and Prime/Boost Time Interval on the Immune Response in Non-human Primates
por: Marcus, Hadar, et al.
Publicado: (2021)

Uncoupling GP1 and GP2 expression in the Lassa virus glycoprotein complex: implications for GP1 ectodomain shedding
por: Illick, Megan M, et al.
Publicado: (2008)

Folding and Oligomerization of the gp2b/gp3/gp4 Spike Proteins of Equine Arteritis Virus in Vitro
por: Kabatek, Aleksander, et al.
Publicado: (2012)

Structure and Characterization of Crimean-Congo Hemorrhagic Fever Virus GP38
por: Mishra, Akaash K., et al.
Publicado: (2020)

Effect of Ebola virus proteins GP, NP and VP35 on VP40 VLP morphology
por: Johnson, Reed F, et al.
Publicado: (2006)

Cellular mRNA triggers structural transformation of Ebola virus matrix protein VP40 to its essential regulatory form
por: Landeras-Bueno, Sara, et al.
Publicado: (2021)

Cultural competency training of GP Registrars-exploring the views of GP Supervisors
por: Watt, Kelly, et al.
Publicado: (2015)

Correction: Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector
por: Khattar, Sunil K., et al.
Publicado: (2014)

To GP or not to GP: a natural experiment in children triaged to see a GP in a tertiary paediatric emergency department (ED)
por: Smith, Laurie, et al.
Publicado: (2018)

GETTING INTO GP TRAINING
por: Steele, Keith
Publicado: (2011)

P-gp and taxanes
por: Hendrikx, Jeroen J.M.A., et al.
Publicado: (2014)

The GP/Hospital Interface
por: Higgins, P. M.
Publicado: (1979)

Zoonotic risk factors associated with seroprevalence of Ebola virus GP antibodies in the absence of diagnosed Ebola virus disease in the Democratic Republic of Congo
por: Bratcher, Anna, et al.
Publicado: (2021)

Evaluating 10 years of state-funded GP training in GP offices in Switzerland
por: Baumann, Kim, et al.
Publicado: (2020)

In silico prediction of Ebola Zaire GP(1,2) immuno-dominant epitopes for the Balb/c mouse
por: Dutta, Debargh K., et al.
Publicado: (2015)

N-Glycans Mediate the Ebola Virus-GP1 Shielding of Ligands to Immune Receptors and Immune Evasion
por: Iraqi, Muhammed, et al.
Publicado: (2020)

Ebola virus glycoprotein GP1—host cell-surface HSPA5 binding site prediction
por: Elfiky, Abdo A.
Publicado: (2020)

Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs
por: Fusco, Marnie L., et al.
Publicado: (2015)

Retraction: Comparative immunogenicity of HIV-1 gp160, gp140 and gp120 expressed by live attenuated newcastle disease virus vector
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dvgidll69ajosiimljglncsoo0